Unilateral cochlea sparing in locoregionally advanced head and neck cancer: a planning study.
L H BraunKatharina BaderB FreyS M WolpertH LöwenheimD ZipsS WelzPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2018)
Unilateral cochlea sparing with an MCD of less than 10 Gy is feasible without compromising the target volume or dose coverage in locoregionally advanced head and neck cancer patients treated with IMRT. A prospective evaluation of the clinical benefit of this approach as well as further investigation of the dose-response relationship for future treatment modification appears promising.